Amgen Ltd

240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)808 0100 321
Medical Information Fax: +44 (0)1223 426 314
Patient Information Leaflet last updated on the eMC: 21/12/2009
PIL ARANESP PFS

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/12/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to instructions about overdose
  • Change to side-effects
Updated on 15/12/2008 and displayed until 21/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 30/10/2008 and displayed until 15/12/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/04/2008 and displayed until 30/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 19/03/2008 and displayed until 21/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to how to administer the medicine
  • Improved Electronic Presentation
Updated on 06/11/2007 and displayed until 19/03/2008
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 06/11/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 26/07/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Introduction of new strength
Updated on 19/01/2007 and displayed until 26/07/2007
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 17/01/2007 and displayed until 19/01/2007
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 14/06/2006 and displayed until 17/01/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 22/03/2006 and displayed until 14/06/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 01/11/2005 and displayed until 22/03/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 27/07/2005 and displayed until 01/11/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 10/05/2004 and displayed until 27/07/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   darbepoetin alfa


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk